JoinClinicalTrials.com

Results

Hot

Post your clinical trial on JoinClinicalTrials.com

Ellijay, Georgia 30536
United States

Post your clinical trial on JoinClinicalTrials.com to reach thousands of viewer daily. Our Clinical Trial Listings have consistently proven to be an ...

• Study to Assess Pharmacokinetics, Safety, and Tolerability of MT-7117 in Subjects With Normal and Impaired Hepatic Function

  NCT04116476

  Condition:   Mild and Moderate Hepatic Impairment
  Intervention:   Drug: MT-7117
  Sponsor:   Mitsubishi Tanabe Pharma Development America, Inc.
  Recruiting
• Longitudinal Cognitive Assessment by BoCA

  NCT04114994

  Conditions:   Alzheimer Disease;   Mild Cognitive Impairment;   Vascular Dementia;   Frontotemporal Dementia;   Parkinson Disease;   Multiple Sclerosis;   TBI
  Intervention:   Diagnostic Test: Boston Cognitive Assessment (BoCA)
  Sponsor:   Alzheimer's Light LLC
  Recruiting
• Phase I Study of D-0120 to Evaluate Safety and PK/PD Study in Healthy Volunteers

  NCT04097405

  Condition:   Healthy Volunteers
  Interventions:   Drug: D-0120;   Drug: Placebo oral tablet
  Sponsor:   InventisBio Inc.
  Recruiting
• Urinalysis Results in Healthy Individuals

  NCT04055675

  Conditions:   Asymptomatic Bacteriuria;   Asymptomatic Pyuria
  Intervention:   Diagnostic Test: Urine dipstick test
  Sponsor:   Kendall Healthcare Group, Ltd.
  Recruiting
• Topical Acetaminophen for Itch Relief: a Proof of Concept Study in Healthy Subjects

  NCT03997851

  Condition:   Pruritus
  Interventions:   Drug: Acetaminophen;   Drug: Carbomer 980
  Sponsor:   University of Miami
  Recruiting
• A Study to Determine the Bioavailability of Lanadelumab (SHP643) Administered Subcutaneously With the Prefilled Syringe and the Autoinjector in Healthy Adult Volunteer Participants.

  NCT03918239

  Condition:   Healthy Volunteers
  Intervention:   Drug: SHP643
  Sponsor:   Shire
  Recruiting
• Viral Conjunctivitis Treatment Study

  NCT03861728

  Condition:   Viral Conjunctivitis
  Interventions:   Device: 0.01% Hypochlorous acid;   Other: Placebo
  Sponsor:   University of Miami
  Recruiting
• Cognition and Neuroplasticity Sedentary Adults After 8 Weeks of Aerobic Exercise

  NCT03804528

  Condition:   Sedentary Behavior
  Intervention:   Behavioral: Aerobic Exercise
  Sponsor:   University of Miami
  Recruiting
• The Effect of Lumify™ Eyedrops on Eyelid Position

  NCT03782701

  Condition:   Eyelid Droop
  Interventions:   Drug: brimonidine tartrate ophthalmic solution 0.025%;   Other: sterile balanced saline solution
  Sponsor:   Wendy Lee
  Recruiting
• Family Men (English Title)

  NCT03730987

  Conditions:   Substance Abuse;   Domestic Violence;   HIV/AIDS
  Interventions:   Behavioral: HoMBReS intervention;   Behavioral: Families Talking Together;   Behavioral: Diabetes Prevention Intervention
  Sponsors:   University of Miami;   National Institute on Minority Health and Health Disparities (NIMHD)
  Recruiting
• Heart Inflammation and Mental Stress Study

  NCT03695146

  Condition:   Hypertension
  Interventions:   Behavioral: Paced breathing;   Behavioral: Active relaxation
  Sponsors:   University of Miami;   National Heart, Lung, and Blood Institute (NHLBI)
  Recruiting
• Postprandial Lipid Tracer and Exercise in Spinal Cord Injury

  NCT03691532

  Condition:   Spinal Cord Injuries
  Interventions:   Behavioral: Seated control (CON);   Behavioral: Arm cycle exercise (ACE);   Behavioral: Liquid meal
  Sponsors:   University of Miami;   The Craig H. Neilsen Foundation
  Recruiting
• Low Intensity Shockwaves Therapy for the Treatment of Erectile Dysfunction. 12- Month Follow-Up

  NCT03670628

  Condition:   Erectile Dysfunction
  Intervention:   Device: Shockwave therapy
  Sponsor:   University of Miami
  Recruiting
• Gentle Jogger and Oxygen Consumption

  NCT03602365

  Conditions:   Physical Inactivity;   Oxygen Consumption
  Intervention:   Device: Gentle Jogger (GJ)
  Sponsor:   Sackner Wellness Products LLC
  Recruiting
• Motivational Interviewing to Increase PrEP Uptake (MI-PrEP)

  NCT03592719

  Condition:   At Risk for HIV
  Interventions:   Behavioral: Experimental Intervention (MI-PrEP);   Behavioral: Enhanced Treatment as Usual (E-TAU)
  Sponsor:   University of Miami
  Recruiting
• Comparing Speedlyte and IV Rehydration Treating Children With Gastroenteritis in a Pediatric Emergency Department (ED)

  NCT03562702

  Conditions:   Dehydration;   Acute Gastroenteritis
  Interventions:   Other: Standard IV Rehydration Therapy;   Other: Oral Rehydration Therapy (ORT)
  Sponsors:   Nicklaus Children's Hospital f/k/a Miami Children's Hospital;   Einsoff Biohealth, LLC
  Recruiting
• Adhear Bone Conduction System

  NCT03533686

  Conditions:   Hearing Loss, Conductive;   Hearing Loss, Unilateral
  Interventions:   Device: Adhear Bone Conduction System;   Device: Standard of Care
  Sponsors:   University of Miami;   Med-El Corporation
  Recruiting
• Disparity Driven Vergence in Mild Traumatic Brain Injury (mTBI)

  NCT03529799

  Condition:   Mild Traumatic Brain Injury
  Intervention:   Device: I-PAS Goggles
  Sponsors:   University of Miami;   Neuro Kinetics
  Recruiting
• TracPatch in Total Knee Arthroplasty

  NCT03466476

  Conditions:   Arthroplasty, Replacement, Knee;   Wearable Electronic Devices
  Intervention:   Device: Consensus TracPatch
  Sponsors:   University of Miami;   Consensus Orthopedics
  Recruiting
• 30-to-90 Day Challenge: Effects of Alcohol Cessation on Health Outcomes

  NCT03353701

  Conditions:   Alcohol Drinking;   Chronic Inflammation;   Neurocognitive Dysfunction;   Liver Diseases;   HIV Infections
  Intervention:   Behavioral: Contingency Management (CM)
  Sponsors:   University of Florida;   University of Miami;   Florida International University;   Brown University;   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
  Recruiting
• Enhancing School Safety Officers' Effectiveness Through Online Professional and Job Embedded Coaching

  NCT03339648

  Conditions:   Bullying;   School Fear;   Professional Role
  Intervention:   Behavioral: Professional Development Enhancement
  Sponsors:   University of Florida;   U.S. Department of Justice
  Recruiting
• Histaminergic Basis of Central Fatigue in Multiple Sclerosis - A Novel Approach

  NCT03266965

  Condition:   Multiple Sclerosis
  Interventions:   Drug: Carbidopa;   Dietary Supplement: L-Histidine
  Sponsors:   University of Miami;   United States Department of Defense
  Recruiting
• Natesto Effects on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Semen Parameters

  NCT03203681

  Condition:   Hypogonadism, Male
  Intervention:   Drug: NATESTO® (4.5% nasal testosterone) Nasal Gel
  Sponsor:   University of Miami
  Recruiting
• Clinical Applications of Advanced Ophthalmic Imaging

  NCT03135327

  Conditions:   Multiple Sclerosis;   Dry Eye Syndromes;   Diabetic Retinopathy;   Presbyopia;   Myopia;   Dementia
  Intervention:   Other: No intervention
  Sponsor:   University of Miami
  Recruiting
• Post-Operative Pain Management Following Spine Surgery

  NCT03076710

  Conditions:   Pain Management;   Analgesia;   Anesthetic
  Interventions:   Drug: Opioids delivered through PCA;   Drug: EXPAREL® infiltration
  Sponsors:   University of Miami;   Pacira Pharmaceuticals, Inc
  Recruiting
• Assessing the Stability of Transcranial Magnetic Stimulation Plasticity Responses

  NCT03034629

  Condition:   Healthy
  Intervention:   Behavioral: Short-term aerobic exercise
  Sponsor:   University of Miami
  Recruiting
• Exercise, Cognitive Function and Neuroplasticity in Healthy Adults

  NCT02994134

  Condition:   Sedentary Lifestyle
  Interventions:   Behavioral: Moderate intensity exercise.;   Behavioral: High intensity exercise.
  Sponsor:   University of Miami
  Recruiting
• Biomechanics of Optic Neuropathy

  NCT02982499

  Condition:   Optic Neuropathy
  Intervention:   Device: magnetic resonance image (MRI)
  Sponsor:   University of Miami
  Recruiting
• Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention

  NCT02970136

  Conditions:   Human Papillomavirus;   Human Immunodeficiency Virus;   Hepatitis C;   ColoRectal Cancer
  Interventions:   Device: OraQuick Swab;   Device: Fecal Immunochemical Test;   Device: OraQuick Fingerstick;   Other: Standard Screening Tests;   Other: HPV Self-Sampling Test
  Sponsors:   University of Miami;   National Institute on Minority Health and Health Disparities (NIMHD)
  Recruiting
• Enhancing STDP After Spinal Cord Injury

  NCT02701777

  Condition:   Spinal Cord Injury
  Interventions:   Drug: Seromycin;   Device: STDP;   Other: Training;   Drug: Dextromethorphan;   Drug: Seromycin Placebo;   Drug: Dextromethorphan Placebo;   Device: Sham STDP
  Sponsors:   VA Office of Research and Development;   University of Miami
  Recruiting
• Evaluation of Acute and Subacute Effects of Nicotine Free Electronic Cigarette(NCFE) Vapors

  NCT02585791

  Condition:   Healthy Lifetime Non-smokers
  Interventions:   Other: Propylene Glycol;   Other: vegetable glycerin;   Other: PG+VG
  Sponsors:   University of Miami;   James and Esther King Biomedical Research Program
  Recruiting
• Remote Ischemic Limb Preconditioning In Healthy Volunteers

  NCT02553655

  Conditions:   Cerebrovascular Disease;   Stroke
  Interventions:   Procedure: 4x 5min Limb Preconditioning;   Procedure: 3x 10min Limb Preconditioning;   Procedure: 3x 10min Sham Preconditioning
  Sponsor:   University of Miami
  Recruiting
• Stop Retinal Ganglion Cell Dysfunction Study

  NCT02390284

  Condition:   Glaucoma
  Interventions:   Drug: Latanoprost;   Drug: Bimatoprost;   Drug: Travoprost;   Drug: Timolol;   Drug: Dorzolamide;   Drug: Brinzolamide;   Drug: Acetazolamide;   Drug: Methazolamide
  Sponsors:   University of Miami;   National Eye Institute (NEI)
  Recruiting
• Immune Reconstitution in Stem Cell Transplant Recipients

  NCT02129543

  Condition:   Cancer
  Intervention:   Procedure: Blood Draw
  Sponsor:   University of Miami
  Recruiting
• Sleep and Emotional Memory in Peripubertal Anxiety

  NCT03643848

  Condition:   Anxiety
  Interventions:   Behavioral: Sleep with Sound Cues;   Behavioral: Sleep with Sham Cues
  Sponsor:   Florida International University
  Recruiting
• Clinical Efficacy of a Non-Invasive Measure of Intracranial Pressure

  NCT03212976

  Conditions:   Intracranial Pathology;   Intracranial Hypertension
  Intervention:   Procedure: Phase contrast magnetic resonance imaging
  Sponsor:   University of Miami
  Recruiting
• Male Fertility Program

  NCT01467869

  Condition:   Spinal Cord Injury
  Intervention:  
  Sponsor:   University of Miami
  Recruiting
• Clinical Research in ALS Study

  NCT00136500

  Condition:   Amyotrophic Lateral Sclerosis
  Intervention:  
  Sponsors:   Michael Benatar;   ALS Association;   ALS Recovery Fund
  Recruiting
• Efficacy of Topical TolaSure on Acute Induced Wounds in Healthy Participants

  NCT04088357

  Condition:   Wound Healing
  Intervention:   Drug: TolaSure Topical Gel
  Sponsors:   BioMendics, LLC;   Symbio, LLC
  Recruiting
• Effect of PF-06651600 on the Pharmacokinetics of Oral Contraceptive Steroids

  NCT04018274

  Condition:   Healthy
  Interventions:   Drug: PF-06651600;   Drug: Ethinyl estradiol (EE) and levonorgestrel(LN)
  Sponsor:   Pfizer
  Recruiting
• A Renal Impairment Study for PF-06651600

  NCT04037865

  Condition:   Renal Impairment
  Intervention:   Drug: PF-06651600
  Sponsor:   Pfizer
  Recruiting
• A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of PF-06651600 in Subjects With Hepatic Impairment and Healthy Volunteers

  NCT04016077

  Conditions:   Hepatic Impairment;   Healthy Participants
  Intervention:   Drug: PF-06651600 30 mg
  Sponsor:   Pfizer
  Recruiting
• Evaluate Severe Hepatic Impairment on Dacomitinib PK

  NCT03865446

  Condition:   Severe Hepatic Impairment
  Intervention:   Drug: Dacomitinib
  Sponsor:   Pfizer
  Recruiting
• Teacher Child Interaction Training (TCIT): Randomized Control Trial

  NCT04000230

  Condition:   Behavior, Child
  Interventions:   Behavioral: TCIT;   Behavioral: Booster
  Sponsors:   University of Miami;   The Children's Trust
  Recruiting
• Pharmacogenetics Sampling of the CC-90007-CP-003 Study Cohort

  NCT04097704

  Condition:   Hepatic Insufficiency
  Intervention:  
  Sponsor:   Celgene
  Recruiting
• A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics and Safety and Tolerability of a Single Oral Dose of Risdiplam Compared to Matched Healthy Participants With Normal Hepatic Function

  NCT03920865

  Condition:   Muscular Atrophy, Spinal
  Intervention:   Drug: Risdiplam
  Sponsor:   Hoffmann-La Roche
  Recruiting
• TRIAL READY (Clinical Trial Readiness)

  NCT03912987

  Conditions:   Amyotrophic Lateral Sclerosis;   Frontotemporal Dementia;   ALS-Frontotemporal Dementia;   Primary Lateral Sclerosis;   Progressive Muscular Atrophy
  Intervention:  
  Sponsors:   University of Miami;   National Institutes of Health (NIH);   National Institute of Neurological Disorders and Stroke (NINDS)
  Recruiting
• The INFORM Study: A Multi-Center Study to Evaluate the Safety and Efficacy of Rotational Fractional Resection on Submental Contouring

  NCT03853980

  Conditions:   Skin Laxity;   Lipodystrophy
  Intervention:   Device: Focal Contouring System
  Sponsor:   Recros Medica, Inc.
  Recruiting
• A Pharmacokinetic Study of Omaveloxolone in Subjects With Hepatic Impairment and Normal Hepatic Function

  NCT03902002

  Condition:   Hepatic Impairment
  Intervention:   Drug: Omaveloxolone 50 mg capsules
  Sponsor:   Reata Pharmaceuticals, Inc.
  Recruiting
• RESCUE Stroke Caregiver Website to Enhance Discharge Planning

  NCT01600131

  Conditions:   Depression;   Quality of Life;   Self Efficacy;   Recovery of Function;   Stress;   Positive Aspects of Caregiving
  Interventions:   Behavioral: Caregiver problem-solving;   Other: Standard Care
  Sponsor:   VA Office of Research and Development
  Recruiting
• A Renal Impairment Study for PF-04965842

  NCT03660241

  Condition:   Renal Impairment
  Intervention:   Drug: PF-04965842
  Sponsor:   Pfizer
  Recruiting
• A Study of Three Different Doses of VAC52416 (ExPEC10V) in Adults Aged 60 to 85 Years in Stable Health

  NCT03819049

  Condition:   Healthy
  Interventions:   Biological: ExPEC10V;   Biological: ExPEC4V;   Biological: Prevnar 13
  Sponsor:   Janssen Research & Development, LLC
  Recruiting
• Remote Wheelchair Skills Training Efficacy

  NCT03499951

  Condition:   Spinal Cord Injuries
  Interventions:   Behavioral: Wheelchair Skills Training - Remote;   Behavioral: Wheelchair Skills Training - In Person
  Sponsors:   University of Pittsburgh;   U.S. Department of Education
  Recruiting
• PRISM 2.0: Field Trial

  NCT03116399

  Condition:   Social Isolation in Older Adults
  Interventions:   Behavioral: PRISM 2.0 Condition;   Behavioral: Tablet Condition
  Sponsors:   University of Miami;   National Institute on Aging (NIA)
  Recruiting
• Effects of Cancer Symptoms on Caregivers

  NCT00351988

  Condition:   Psychosocial
  Interventions:   Behavioral: Phenomenological Interviews;   Behavioral: Quantitative Interviews
  Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
  Recruiting
• Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms

  NCT00443274

  Condition:   Breast Implant
  Interventions:   Other: NBIR Placeholder;   Device: 410 Arm;   Device: BIFs
  Sponsor:   Allergan
  Recruiting
• Study to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine Given With Prevnar 13 in Healthy Infants

  NCT03550313

  Condition:   Pneumococcal Infections
  Interventions:   Biological: Multivalent;   Biological: Prevnar 13
  Sponsor:   Pfizer
  Recruiting
• Study to Assess the Relationship Between Daily Dosing of NRPT and Changes in Liver Fat in Healthy Volunteers

  NCT03513523

  Condition:   Fatty Liver
  Interventions:   Dietary Supplement: Group 1 NRPT;   Dietary Supplement: Group 2 NRPT;   Other: Group 3 Placebo
  Sponsors:   Elysium Health;   Nutrasource Diagnostics Inc.
  Recruiting
• Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

  NCT03691610

  Condition:   Healthy Volunteers (Meningococcal Infection)
  Interventions:   Biological: Meningococcal Polysaccharide (Serogroups A,C,Y and W) Tetanus Toxoid Conjugate vaccine MenACYW conjugate vaccine;   Biological: Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine;   Biological: Meningococcal Polysaccharide (serogroups A,C,Y and W-135) Diphtheria Toxoid Conjugate Vaccine;   Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis, inactivated Poliovirus and Haemophilus b Conjugate Vaccine;   Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis, Hepatitis B and Inactivated Poliovirus Vaccine;   Biological: Haemophilus b Conjugate Vaccine;   Biological: Pneumococcal 13-valent Conjugate Vaccine;   Biological: Rotavirus Vaccine, Live, Oral, Pentavalent;   Biological: Hepatitis B Vaccine;   Biological: Measles, Mumps, and Rubella Virus Vaccine Live;   Biological: Varicella Virus Vaccine Live
  Sponsor:   Sanofi Pasteur, a Sanofi Company
  Recruiting
• Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

  NCT03673462

  Condition:   Healthy Volunteers (Meningococcal Infection)
  Interventions:   Biological: Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid conjugate vaccine (MenACYW conjugate vaccine);   Biological: Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine (MENVEO®);   Biological: Diphtheria, Tetanus, Acellular Pertussis, Poliovirus and Haemophilus b Vaccine;   Biological: Pneumococcal 13-valent Conjugate Vaccine;   Biological: Rotavirus Vaccine;   Biological: Hepatitis B Vaccine;   Biological: Measles, Mumps, and Rubella Virus Vaccine;   Biological: Varicella Virus Vaccine
  Sponsor:   Sanofi Pasteur, a Sanofi Company
  Recruiting
• Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia

  NCT02003222

  Conditions:   Acute Lymphoblastic Leukemia;   B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
  Interventions:   Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;   Biological: Blinatumomab;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Daunorubicin Hydrochloride;   Drug: Dexamethasone;   Drug: Etoposide;   Other: Laboratory Biomarker Analysis;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Pegaspargase;   Drug: Prednisone;   Biological: Rituximab;   Drug: Vincristine Sulfate
  Sponsors:   National Cancer Institute (NCI);   Canadian Cancer Trials Group
  Recruiting
• The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 2)

  NCT03653611

  Condition:   Chronic Obstructive Pulmonary Disease (COPD)
  Interventions:   Other: On-site Practice Assessment;   Other: Clinical Staff Questionnaires;   Other: Patient Opinion Surveys;   Other: Modular online COPD Education;   Other: COPD in Primary Care/CAPTURE Introduction Focus Groups
  Sponsors:   Weill Medical College of Cornell University;   National Heart, Lung, and Blood Institute (NHLBI);   University of Michigan;   National Jewish Health;   Atrium Health;   Duke University;   High Plains Research Network;   L.A. Net Community Health Resource Network;   Oregon Health and Science University;   University of Minnesota - Clinical and Translational Science Institute;   University of Kentucky;   COPD Foundation
  Recruiting
• The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 1)

  NCT03581227

  Condition:   Chronic Obstructive Pulmonary Disease (COPD)
  Intervention:   Other: CAPTURE Tool
  Sponsors:   Weill Medical College of Cornell University;   National Heart, Lung, and Blood Institute (NHLBI);   University of Michigan;   National Jewish Health;   University of Minnesota - Clinical and Translational Science Institute;   Duke University;   Atrium Health;   Oregon Health and Science University;   High Plains Research Network;   L.A. Net Community Health Resource Network;   COPD Foundation;   University of Kentucky
  Recruiting
• Novel MRI Biomarkers for Monitoring Disease Progression in ALS

  NCT03362658

  Conditions:   Amyotrophic Lateral Sclerosis;   Motor Neuron Disease
  Intervention:  
  Sponsors:   University of Alberta;   University of Calgary;   Western University, Canada;   McGill University;   University of Toronto;   University of British Columbia;   Laval University;   University of Miami;   University of Utah
  Recruiting
• Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

  NCT04015375

  Condition:   Acne Vulgaris
  Interventions:   Drug: Dapsone gel 7.5% (Torrent Pharmaceuticals Ltd);   Drug: ACZONE® (dapsone) gel, 7.5% (Allergan, INC.);   Other: Placebo for Dapsone gel 7.5% (Torrent Pharmaceuticals Ltd)
  Sponsors:   Torrent Pharmaceuticals Limited;   Catawba Research
  Recruiting
• Safety, Tolerability, and Pharmacokinetics of MK-1654 in Infants (MK-1654-002)

  NCT03524118

  Conditions:   Respiratory Tract Infection;   Respiratory Syncytial Virus
  Interventions:   Drug: MK-1654;   Drug: Placebo
  Sponsor:   Merck Sharp & Dohme Corp.
  Recruiting
• The Lung Screening, Tobacco and Health Project

  NCT03200236

  Conditions:   Smoking, Tobacco;   Tobacco-Related Carcinoma;   Tobacco Use;   Lung Cancer Screening
  Interventions:   Behavioral: Intensive Telephone Counseling (8 sessions) with nicotine replacement;   Behavioral: Usual Care: Telephone counseling (3 sessions) with nicotine replacement
  Sponsors:   Georgetown University;   Hackensack Meridian Health;   Baptist Health South Florida;   Hartford HealthCare;   Lahey Hospital & Medical Center;   University of Michigan;   National Cancer Institute (NCI);   UnityPoint Health;   MedStar Shah Medical Group;   Anne Arundel Medical Center
  Recruiting
• Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women

  NCT00539162

  Condition:   Ovarian Cancer
  Interventions:   Behavioral: Questionnaire;   Procedure: CA 125 Analysis;   Procedure: Transvaginal Ultrasound
  Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI);   Golfers Against Cancer
  Recruiting
• Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Platysmal Bands

  NCT04080882

  Condition:   Platysmal Bands
  Interventions:   Biological: AbobotulinumtoxinA dose 1;   Other: Placebo;   Biological: AbobotulinumtoxinA dose 2
  Sponsor:   Q-Med AB
  Recruiting
• Growth and Tolerance of Infants Fed Milk-Based Infant Formula

  NCT03967132

  Condition:   Gastro-Intestinal Tolerance
  Interventions:   Other: Control Infant Formula;   Other: Experimental Infant Formula;   Other: Reference Group
  Sponsor:   Abbott Nutrition
  Recruiting
• Evaluation of Revised Indicatons (ERID) for Cochlear Implant Candidacy for the Adult CMS Population

  NCT02075229

  Condition:   Bilateral Sensorineural Hearing Loss
  Intervention:   Device: Cochlear implant
  Sponsors:   American Cochlear Implant Alliance;   University of Michigan;   University of Iowa;   Johns Hopkins University;   University of Miami;   NYU Langone Health;   University of North Carolina;   University of Southern California;   Vanderbilt University;   University of Washington;   Washington University School of Medicine;   Loyola University Chicago;   University of Pennsylvania;   University of Texas;   Saint Luke's Health System;   Massachusetts Eye and Ear Infirmary;   Medical College of Wisconsin;   Medical University of South Carolina;   Ohio State University;   Rocky Mountain Ear Center Audiology and Ear Services
  Recruiting
• A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Moderate to Severe Crohn's Disease

  NCT03358706

  Condition:   Crohn Disease
  Interventions:   Drug: Ustekinumab IV Infusion;   Drug: Ustekinumab SC Injection;   Drug: Midazolam 2 mg;   Drug: Warfarin 10 mg;   Drug: Vitamin K 10 mg;   Drug: Omeprazole 20 mg;   Drug: Dextromethorphan 30 mg;   Drug: Caffeine 100 mg
  Sponsor:   Janssen Research & Development, LLC
  Recruiting
• BOTOX Treatment of Masseter Muscle Prominence

  NCT03861936

  Condition:   Masseter Muscle Prominence
  Interventions:   Biological: Botulinum toxin type A;   Drug: Normal saline
  Sponsor:   Allergan
  Recruiting
• Clinical Study of a Diagnostic Device for NG, TV and CT in Women

  NCT03852316

  Conditions:   Chlamydial Infection;   Gonococcal Infection;   Trichomoniasis
  Intervention:   Device: Click Device
  Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
  Recruiting
• Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

  NCT03761914

  Conditions:   Acute Myelogenous Leukemia;   Ovarian Cancer;   Colorectal Cancer;   Triple-negative Breast Cancer;   Small-cell Lung Cancer
  Interventions:   Biological: galinpepimut-S;   Drug: Pembrolizumab
  Sponsors:   Sellas Life Sciences Group;   Merck Sharp & Dohme Corp.;   Cancer Insight, LLC
  Recruiting
• Phenotype, Genotype & Biomarkers in ALS and Related Disorders

  NCT02327845

  Conditions:   Amyotrophic Lateral Sclerosis;   Frontotemporal Dementia;   Primary Lateral Sclerosis;   Hereditary Spastic Paraplegia;   Progressive Muscular Atrophy;   Multisystem Proteinopathy
  Intervention:  
  Sponsors:   University of Miami;   National Institute of Neurological Disorders and Stroke (NINDS);   National Center for Advancing Translational Science (NCATS);   St. Jude Children's Research Hospital;   ALS Association
  Recruiting
• Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects

  NCT04074928

  Condition:   Influenza, Human
  Interventions:   Biological: QIVc;   Biological: Comparator QIV
  Sponsor:   Seqirus
  Recruiting
• A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Late Preterm and Term Infants

  NCT03979313

  Condition:   Respiratory Syncytial Virus Infections
  Interventions:   Drug: MEDI8897;   Drug: Placebo
  Sponsor:   MedImmune LLC
  Recruiting
• Outcomes Mandate National Integration With Cannabis as Medicine

  NCT03944447

  Conditions:   Chronic Pain;   Chronic Pain Syndrome;   Chronic Pain Due to Injury;   Chronic Pain Due to Trauma;   Fibromyalgia;   Seizures;   Hepatitis C;   Cancer;   Crohn Disease;   HIV/AIDS;   Multiple Sclerosis;   Traumatic Brain Injury;   Sickle Cell Disease;   Post Traumatic Stress Disorder;   Tourette Syndrome;   Ulcerative Colitis;   Glaucoma;   Epilepsy;   Inflammatory Bowel Diseases;   Parkinson Disease;   Amyotrophic Lateral Sclerosis;   Chronic Traumatic Encephalopathy;   Anxiety;   Depression;   Insomnia;   Autism;   Opioid-use Disorder;   Bipolar Disorder
  Intervention:   Drug: Cannabis, Medical
  Sponsor:   OMNI Medical Services, LLC
  Recruiting
• Clostridium Difficile Vaccine 2-Dose Versus 3-Dose Study

  NCT03918629

  Condition:   Clostridium Difficile Associated Disease
  Interventions:   Biological: Clostridium difficile;   Biological: Placebo
  Sponsor:   Pfizer
  Recruiting
• Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029)

  NCT03893448

  Conditions:   Pneumococcal Infections;   Pneumococcal Vaccines
  Interventions:   Biological: V114;   Biological: Prevnar 13™;   Biological: RotaTeq™;   Biological: Pentacel™;   Biological: RECOMBIVAX HB™;   Biological: VAQTA™;   Biological: M-M-R™;   Biological: VARIVAX™;   Biological: HIBERIX™
  Sponsor:   Merck Sharp & Dohme Corp.
  Recruiting
• Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris

  NCT03664752

  Condition:   Acne Vulgaris
  Interventions:   Drug: IDP-120 Gel;   Drug: IDP-120 Vehicle Gel
  Sponsor:   Bausch Health Americas, Inc.
  Recruiting
• Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US

  NCT03537508

  Condition:   Meningococcal Infections
  Interventions:   Biological: MenACYW conjugate vaccine;   Biological: MenACYW-135 conjugate vaccine;   Biological: DTaP-IPV//Hib vaccine;   Biological: Pneumococcal 13-valent conjugate vaccine;   Biological: Pentavalent rotavirus vaccine;   Biological: Hepatitis B vaccine;   Biological: Measles, mumps, rubella (MMR) vaccine;   Biological: Varicella vaccine;   Biological: Hepatitis A vaccine
  Sponsor:   Sanofi Pasteur, a Sanofi Company
  Recruiting
• Growth and Tolerance of Infants Fed Formula for 16 Weeks

  NCT03487094

  Condition:   Child Development
  Intervention:   Other: Infant formula
  Sponsor:   Nature's One
  Recruiting
• Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry

  NCT03326076

  Condition:   Kidney Transplant Rejection
  Interventions:   Diagnostic Test: Donor-derived cell-free DNA (AlloSure®);   Other: Standard care
  Sponsor:   CareDx
  Recruiting
• Study to Assess Outcomes in Women Undergoing Either Hysteroscopic Sterilization (Essure®) or Laparoscopic Tubal Sterilization

  NCT03127722

  Condition:   Contraception
  Interventions:   Procedure: Blood draw;   Device: ESSURE (BAY1454032);   Procedure: Laparoscopic tubal sterilization
  Sponsor:   Bayer
  Recruiting
• Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network

  NCT02450851

  Condition:   Genetic Disease
  Intervention:  
  Sponsor:   National Human Genome Research Institute (NHGRI)
  Recruiting
• Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men

  NCT02720094

  Condition:   HIV Infections
  Interventions:   Drug: Cabotegravir tablets;   Drug: TDF/FTC tablets;   Drug: TDF/FTC placebo tablets;   Drug: CAB placebo tablets;   Drug: CAB LA;   Drug: Placebo for CAB LA
  Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   ViiV Healthcare;   Gilead Sciences
  Recruiting
• Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others

  NCT01193075

  Condition:   Charcot Marie Tooth Disease
  Intervention:  
  Sponsors:   Michael Shy;   Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta;   Johns Hopkins University;   National Institute of Neurological Disorders and Stroke (NINDS);   King's College Hospital NHS Trust;   Nemours Children's Clinic;   Stanford University;   University of Pennsylvania;   University of Rochester;   Children's Hospital of Philadelphia;   Sydney Children's Hospitals Network;   Rare Diseases Clinical Research Network;   Muscular Dystrophy Association;   National Institutes of Health (NIH);   Charcot-Marie-Tooth Association;   Massachusetts General Hospital;   Cedars-Sinai Medical Center;   University of Miami;   Dubowitz Neuromuscular Centre;   University of Minnesota - Clinical and Translational Science Institute;   University of Connecticut;   University of Colorado, Denver;   Detroit Medical Center;   Ohio State University
  Recruiting
• Surveillance Monitoring for ART Toxicities Study in HIV Uninfected Children Born to HIV Infected Women

  NCT01310023

  Condition:   Antiretroviral Toxicity
  Intervention:  
  Sponsors:   Harvard School of Public Health;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   National Institute on Drug Abuse (NIDA);   National Institute of Allergy and Infectious Diseases (NIAID);   National Institute of Mental Health (NIMH);   National Heart, Lung, and Blood Institute (NHLBI);   National Institute on Deafness and Other Communication Disorders (NIDCD);   National Institute on Alcohol Abuse and Alcoholism (NIAAA);   National Institute of Neurological Disorders and Stroke (NINDS);   Tulane University School of Medicine;   National Institute of Dental and Craniofacial Research (NIDCR);   NIH Office of AIDS Research (OAR)
  Recruiting
• Pathway to Prevention Study

  NCT00097292

  Condition:   Diabetes Mellitus, Type 1
  Intervention:  
  Sponsors:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   National Institute of Allergy and Infectious Diseases (NIAID);   National Center for Research Resources (NCRR);   Juvenile Diabetes Research Foundation;   American Diabetes Association
  Recruiting